Login | Register

News & Analysis

A new wave of US biosimilar patent disputes begins
A new wave of US biosimilar patent disputes begins

After a lull in biologic versus imitator disputes, Regeneron has sued Mylan and more litigation is likely to follow

The patent challenges of the Indian company set to become the world’s biggest biosimilars business
The patent challenges of the Indian company set to become the world’s biggest biosimilars business

In an exclusive interview Biocon Biologics’ chief IP counsel explains the issues that he and his team focus on – and how an upcoming, big-ticket merger will lead to change

IPValue – the licensing business that rarely goes to court
IPValue – the licensing business that rarely goes to court

Despite holding thousands of patents and being active for over 20 years, Docket Navigator data shows that the firm’s entities have filed just 32 litigation actions since 2008

Latest content

Brexit was my toughest challenge, says outgoing UK IP Office head

In an exclusive interview, Tim Moss talks through the five years he spent leading the agency and provides an update on its current study of SEP/FRAND policy issues

02 August 2022

Chinese invention patent grants up 16% in the first half of 2022

Domestic entities lead the charge, with authorities also keen to encourage further international filings

02 August 2022

WDTX judges on new random assignment list lack patent experience

Filing in Waco now seems a real gamble, as a deep dive on Docket Navigator reveals that most of Alan Albright’s colleagues have handled a relatively low number of cases

01 August 2022

Major Avanci hire signals serious push into new licensing areas

Marianne Frydenlund joins the firm from Nordic Semicondustor with a brief to develop solutions for IoT-related sectors beyond auto

01 August 2022

IP tax strategies come under fire from US senators

Legislators put pharma companies under the microscope and blame a law signed by President Trump in 2017 for patent-based payment mitigation

01 August 2022

Major WDTX change side-lines Albright; 101 legislation imminent; Seven-year Qualcomm and Samsung patent deal; ResMed’s IP secrets; Diversity at Meta; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

31 July 2022

Developments at the EPO on patenting AI-assisted inventions require close scrutiny

A recent decision handed down by the Boards of Appeal may mean greater patenting opportunities for innovators using AI to help create their inventions

30 July 2022

IP and innovation inclusion takes a village: a Meta perspective

As the Advancing Diversity Across Patent Teams programme launches, Micheal L Binns expands on the company’s DEI efforts

29 July 2022

Sanofi farms out more IP as part of “play to win” strategy

The French company is one of several big pharmas to have offloaded deprioritised drugs in recent months

29 July 2022

How ResMed uses IP to build business value

Michael Pinczuk and his colleague Keira Moore explain that deep thinking about strategy and communication have paid dividends for the leading medtech company

29 July 2022

Get unlimited access to all IAM content

Subscribe Now